Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
With
M.D. Anderson Cancer Center
Maimonides Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Rutgers University
Tampa General Hospital
University of California, Los Angeles
National Cancer Institute (NCI)
Monash University
Weill Cornell Medical College in Qatar
New York Presbyterian Brooklyn Methodist Hospital
San Francisco State University
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Physicians:
who treat patients with DLBCL and HD as per self report
Patients of Physicians:
have a new diagnosis of Hodgkin's or Diffuse Large B-cell Lymphoma as per pathology report or physician assessment in medical record and/or clinical judgment of the treating physician treated with curative intent.
For part 1 - have scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
For part 2 (longitudinal phase): - have new scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
be at least 18 years old
speak English well enough, in the judgment of the consenting professional, to be able to understand all aspects of the study, provide informed consent, and be able to complete all study measures.
You may not be if
Physicians:
who do not have adequate patients in their clinical practice to meet the 8 patient enrollment requirement for patients with either DLBCL or HD as per self report
Patients of Physicians:
show evidence of cognitive impairment severe enough to preclude giving permission to the study staff, or completing the survey instruments of the study.
as per physician judgment, patient's prognosis and/or co-morbidities make them inappropriate for participation in a survivorship study.
For Part 2 ONLY (longitudinal phase):
those who consented to part 1, consult recording, of the study.
Clareo Health | Communication Skills Intervention to Promote Transition Into Survivorship
